• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静默性低氧血症:COVID-19 患者临床恶化的先兆。

Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19.

机构信息

Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, United States of America.

Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, United States of America.

出版信息

Am J Emerg Med. 2020 Oct;38(10):2243.e5-2243.e6. doi: 10.1016/j.ajem.2020.05.044. Epub 2020 May 22.

DOI:10.1016/j.ajem.2020.05.044
PMID:32471783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7243756/
Abstract

Patients infected with the SARS-CoV-2 virus can present with a wide variety of symptoms including being entirely asymptomatic. Despite having no or minimal symptoms, some patients may have markedly reduced pulse oximetry readings. This has been referred to as "silent" or "apathetic" hypoxia (Ottestad et al., 2020 [1]). We present a case of a 72-year-old male with COVID-19 syndrome who presented to the emergency department with minimal symptoms but low peripheral oxygen saturation readings. The patient deteriorated over the following days and eventually died as a result of overwhelming multi-organ system failure. This case highlights the utility of peripheral oxygen measurements in the evaluation of patients with SARS-CoV-2 infection. Self-monitoring of pulse oximetry by patients discharged from the emergency department is a potential way to identify patients needing to return for further evaluation.

摘要

感染 SARS-CoV-2 病毒的患者可能出现各种症状,包括完全无症状。尽管没有或仅有轻微的症状,一些患者的脉搏血氧饱和度读数可能明显降低。这被称为“无声”或“冷漠”性缺氧(Ottestad 等人,2020 [1])。我们报告了一例 COVID-19 综合征的 72 岁男性患者,他因症状轻微但外周血氧饱和度读数低而到急诊就诊。患者在接下来的几天里病情恶化,最终因多器官系统衰竭而死亡。该病例强调了外周血氧测量在评估 SARS-CoV-2 感染患者中的效用。从急诊出院的患者自行监测脉搏血氧饱和度可能是识别需要返回进一步评估的患者的一种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ef/7243756/113542dece18/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ef/7243756/113542dece18/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ef/7243756/113542dece18/gr1_lrg.jpg

相似文献

1
Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19.静默性低氧血症:COVID-19 患者临床恶化的先兆。
Am J Emerg Med. 2020 Oct;38(10):2243.e5-2243.e6. doi: 10.1016/j.ajem.2020.05.044. Epub 2020 May 22.
2
Early Detection of Silent Hypoxia in Covid-19 Pneumonia Using Smartphone Pulse Oximetry.使用智能手机脉搏血氧仪早期检测新冠病毒肺炎中的沉默性低氧血症
J Med Syst. 2020 Jun 19;44(8):134. doi: 10.1007/s10916-020-01587-6.
3
Platypnea-orthodeoxia in a patient with severe COVID-19 pneumonia.严重 COVID-19 肺炎患者的平卧位呼吸窘迫-直立性低氧血症。
Monaldi Arch Chest Dis. 2020 Dec 23;90(4). doi: 10.4081/monaldi.2020.1609.
4
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?新冠病毒患者目标血氧饱和度的考虑因素:我们是否设定得过低?
BMC Med. 2020 Aug 19;18(1):260. doi: 10.1186/s12916-020-01735-2.
5
Silent hypoxia in COVID-19: pathomechanism and possible management strategy.新型冠状病毒肺炎静默性低氧血症:发病机制与可能的管理策略。
Mol Biol Rep. 2021 Apr;48(4):3863-3869. doi: 10.1007/s11033-021-06358-1. Epub 2021 Apr 23.
6
Clinical and radiological findings of silent hypoxia among COVID-19 patients.新型冠状病毒肺炎患者静默低氧血症的临床和影像学特征。
J Infect Chemother. 2021 Oct;27(10):1536-1538. doi: 10.1016/j.jiac.2021.07.002. Epub 2021 Jul 8.
7
Silent hypoxia: a frequently overlooked clinical entity in patients with COVID-19.沉默性低氧血症:COVID-19患者中一种常被忽视的临床病症。
BMJ Case Rep. 2020 Sep 7;13(9):e237207. doi: 10.1136/bcr-2020-237207.
8
Hypoxia and thrombosis in COVID-19: new considerations for air passengers.新型冠状病毒肺炎中的缺氧与血栓形成:航空旅客的新考量
J Travel Med. 2020 Dec 23;27(8). doi: 10.1093/jtm/taaa122.
9
[Pulse oximetry: Role in the COVID-19 patient at home].[脉搏血氧饱和度测定:在居家新冠患者中的作用]
Semergen. 2022 Jan-Feb;48(1):70-77. doi: 10.1016/j.semerg.2021.03.004. Epub 2021 Apr 20.
10
SARS-CoV-2 infection, pulse oximetry, and interpretive caveats.SARS-CoV-2 感染、脉搏血氧饱和度测定法及解读注意事项。
Trop Doct. 2022 Oct;52(4):593-595. doi: 10.1177/00494755221094983. Epub 2022 Jul 1.

引用本文的文献

1
EVALUATION OF PATIENTS WITH COVID-19 IN THE EARLY HYPOXEMIC STAGE AND PATIENTS WITH VIRAL RESPIRATORY TRACT INFECTION IN TERMS OF PULMONARY HYPERTENSION.评估 COVID-19 早期低氧血症患者和病毒性呼吸道感染患者的肺动脉高压。
Acta Clin Croat. 2023 Nov;62(3):478-485. doi: 10.20471/acc.2023.62.03.10.
2
Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms.新冠病毒症状学的全患者知识建模揭示了常见分子机制。
Front Mol Med. 2023 Jan 4;2:1035290. doi: 10.3389/fmmed.2022.1035290. eCollection 2022.
3
Evaluation of the predictors and frequency of silent hypoxemia in COVID-19 patients and the gap between pulse oximeter and arterial blood gas levels: A cross-sectional study.

本文引用的文献

1
COVID-19 with silent hypoxemia.伴有静息性低氧血症的新型冠状病毒肺炎
Tidsskr Nor Laegeforen. 2020 Apr 11;140(7). doi: 10.4045/tidsskr.20.0299. Print 2020 May 5.
2
COVID-19 patients with respiratory failure: what can we learn from aviation medicine?患有呼吸衰竭的新冠肺炎患者:我们能从航空医学中学到什么?
Br J Anaesth. 2020 Sep;125(3):e280-e281. doi: 10.1016/j.bja.2020.04.012. Epub 2020 Apr 18.
3
Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study.新型冠状病毒肺炎机械通气患者的呼吸病理生理学:一项队列研究
COVID-19患者无症状性低氧血症的预测因素、发生率及脉搏血氧饱和度与动脉血气水平之间的差距评估:一项横断面研究。
Health Care Sci. 2024 Jun 17;3(3):172-180. doi: 10.1002/hcs2.98. eCollection 2024 Jun.
4
Equity-Driven Sensing System for Measuring Skin Tone-Calibrated Peripheral Blood Oxygen Saturation (OptoBeat): Development, Design, and Evaluation Study.用于测量肤色校准外周血氧饱和度的公平驱动传感系统(OptoBeat):开发、设计与评估研究
JMIR Biomed Eng. 2022 Apr 22;7(1):e34934. doi: 10.2196/34934.
5
Happy hypoxemia in COVID-19 patients: Fact or myth?新冠病毒肺炎患者的快乐低氧血症:事实还是谬论?
J Anaesthesiol Clin Pharmacol. 2024 Jan-Mar;40(1):169-171. doi: 10.4103/joacp.joacp_171_22. Epub 2024 Feb 8.
6
Home Pulse Oximetry Monitoring during the COVID-19 Pandemic: An Assessment of Patient Engagement and Compliance.新冠疫情期间的家庭脉搏血氧饱和度监测:患者参与度与依从性评估
Health Policy Technol. 2023 Jun 26:100776. doi: 10.1016/j.hlpt.2023.100776.
7
Lung repair and regeneration: Advanced models and insights into human disease.肺修复与再生:人类疾病的先进模型与新见解。
Cell Stem Cell. 2024 Apr 4;31(4):439-454. doi: 10.1016/j.stem.2024.02.009. Epub 2024 Mar 15.
8
O2 supplementation disambiguation in clinical narratives to support retrospective COVID-19 studies.在临床叙述中对 O2 补充的歧义进行澄清,以支持回顾性 COVID-19 研究。
BMC Med Inform Decis Mak. 2024 Jan 31;24(1):29. doi: 10.1186/s12911-024-02425-2.
9
Continuous aerosol monitoring and comparison of aerosol exposure based on smoke dispersion distance and concentrations during oxygenation therapy.持续气溶胶监测以及基于供氧治疗期间烟雾扩散距离和浓度的气溶胶暴露比较。
Sci Rep. 2023 Sep 23;13(1):15910. doi: 10.1038/s41598-023-42909-1.
10
Coronavirus Disease-2019 Pneumonia: Clinical Manifestations.新型冠状病毒肺炎的临床特征。
Clin Chest Med. 2023 Jun;44(2):227-237. doi: 10.1016/j.ccm.2022.11.006. Epub 2022 Nov 23.
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560-1564. doi: 10.1164/rccm.202004-1163LE.
4
COVID-19 pneumonia: different respiratory treatments for different phenotypes?新冠肺炎:针对不同表型采用不同的呼吸治疗方法?
Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.
5
COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.新冠病毒肺炎不会导致“典型的”急性呼吸窘迫综合征。
Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. doi: 10.1164/rccm.202003-0817LE.
6
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.人类心脏中的 ACE2 表达表明了 SARS-CoV-2 感染患者心脏损伤的新潜在机制。
Cardiovasc Res. 2020 May 1;116(6):1097-1100. doi: 10.1093/cvr/cvaa078.
7
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
8
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
9
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.两例肺癌患者 2019 年新型冠状病毒(COVID-19)肺炎早期阶段的肺部病理学表现。
J Thorac Oncol. 2020 May;15(5):700-704. doi: 10.1016/j.jtho.2020.02.010. Epub 2020 Feb 28.
10
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.